LONDON, England, Nov. 16 -- Future Oncology, a peer-reviewed journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 20, Issue 37 edition:

Rapid Communications

* Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study

* Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had . . .

Click here for more information about our products